Prescription drug · ANDA
Methocarbamol (methocarbamol tablets) NDC 70010-770
Methocarbamol 750 mg/1 · Tablet, Coated · Oral · Granules Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70010-770-01 | 70010077001 | 100 TABLET, COATED in 1 BOTTLE (70010-770-01)Marketed from Feb 1, 2020 | |
| 70010-770-05 | 70010077005 | 500 TABLET, COATED in 1 BOTTLE (70010-770-05)Marketed from Feb 1, 2020 | |
| 70010-770-10 | 70010077010 | 1000 TABLET, COATED in 1 BOTTLE (70010-770-10)Marketed from Feb 1, 2020 | |
| 70010-770-35 | 70010077035 | 24 TABLET, COATED in 1 BOTTLE (70010-770-35)Marketed from Feb 1, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methocarbamol
- Generic name (nonproprietary)
- methocarbamol tablets
- Active ingredients
- Methocarbamol — 750 mg/1
- Dosage form
- Tablet, Coated
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209312
- Marketing start
- Listing expires
- Other FDA classes
- Centrally-mediated Muscle Relaxation (Physiologic effect)
- Identifiers
- Product ID 70010-770_56016dcc-153e-f9be-e063-6294a90ab407SPL ID 56016dcc-153e-f9be-e063-6294a90ab407SPL set ID 6f0d3966-962d-fa7c-e053-2a91aa0a8e3cRxCUI 197943, 197944UNII 125OD7737X
- Pharmacologic class
- Muscle Relaxant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470010077001followed by a unit qualifier and the quantityPackage 70010-0770-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 209312
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | NuCare Pharmaceuticals,Inc. | 68071-4505 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Coupler LLC | 67046-0340 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | NuCare Pharmaceuticals,Inc. | 68071-4520 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | PD-Rx Pharmaceuticals, Inc. | 43063-903 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | PD-Rx Pharmaceuticals, Inc. | 43063-905 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | Granules India Ltd | 62207-754 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | REMEDYREPACK INC. | 70518-4501 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Granules India Ltd | 62207-770 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Preferred Pharmaceuticals Inc. | 68788-8172 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Pharmasource Meds, LLC | 82982-038 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Proficient Rx LP | 71205-068 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | St. Mary's Medical Park Pharmacy | 60760-770 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | Coupler LLC | 67046-0538 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-134 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | Preferred Pharmaceuticals Inc. | 68788-8213 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | Redpharm Drug | 67296-2197 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | Unit Dose Solutions, Inc. | 87441-086 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | Northwind Health Company, LLC | 51655-195 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Redpharm Drug | 67296-2203 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Northwind Health Company, LLC | 51655-205 |
Showing 20 of 39.